Skip to main content

Contact us for your consultation (706) 250-1960

Follow up to February 2014 Harman Law Post: FDA Requires Label Change Citing Increased Blood Clot Risk with Testosterone Products

On June 19, 2014 the FDA announced they are requiring manufacturers of testosterone therapy products (“TT”) to add blood clot warnings to the drug labeling. The testosterone products include:

  • Axiron
  • AndroDerm
  • AndroGel (the biggest seller and creator of the marketing term “LowT”)
  • Delatestryl
  • Fortesta
  • Striant
  • Testim
  • Testopel

See the February 2014 Harman Law post on testosterone therapy: Testosterone Therapy Rx Linked to Increased Risk of Heart Attack, Stroke and Potentially Fatal Conditions

Harman Law is representing men who have experienced heart attacks, strokes or blood clots after taking testosterone therapy as well as men who develop prostate cancer after long-term “TT.”

Posted on behalf of Harman Law Firm

Contact Us


    Harman Law Firm

    4.8 / 5.0

    Based on 23 reviews


    Matt has been a warrior during our long and difficult battle for justice.


    After my grandparents were victims of fraud, Matt fought for their rights.

    Denise B.

    When my child died because of gross negligence, the Harman Law Firm got justice for his memory.


    3975 Roswell Road NE
    Atlanta, GA, 30342
    Phone: (404) 554-0777

    Free consultation


    3540 Wheeler Rd #603
    Augusta, GA, 30909
    Phone: (706) 250-1960

    Free consultation